F10 and atrial fibrillation: The Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction (ENGAGE AF-TIMI) trial had ~36% diabetic participants (Giugliano et al., 2013).